Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2007; 13(42): 5642-5647
Published online Nov 14, 2007. doi: 10.3748/wjg.v13.i42.5642
Published online Nov 14, 2007. doi: 10.3748/wjg.v13.i42.5642
Table 1 Baseline characteristics of the patients
| Lam-200 | Lam-100 | P | |
| Number of patients | 12 | 35 | NS |
| Age (median; range) | 44.5 (32-60) | 44 (23-72) | NS |
| BMI median (range) | 24.3 (23.2-28.7) | 25.5 (20.9-34.3) | NS |
| Gender (M/F) | 11/1 | 26/9 | NS |
| Histology | NS | ||
| Minimal-Mild | 1 (14%) | 6 (22%) | |
| Moderate-Severe | 3 (43%) | 7 (26%) | |
| Cirrhosis | 3 (43%) | 14 (52%) | |
| ALT (x n.v.) | NS | ||
| < 3 | 4 (33.3%) | 16 (50%) | |
| 3-5 | 3 (25%) | 5 (15.6%) | |
| > 5 | 5 (41.7%) | 11 (34.4%) | |
| HBV-DNA IU/mL median (range) | 1.06 × 106 (3.2 × 104-3.8 × 106) | 6 × 105 (2.4 × 104-3.5 × 106) | NS |
| Months of therapy median (range) | 28 (8-50) | 28 (9-48) | NS |
- Citation: Stornaiuolo G, Stanzione M, Brancaccio G, Cuomo G, Precone V, Di Biase S, Felaco FM, Piccinino F, Gaeta GB. Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B. World J Gastroenterol 2007; 13(42): 5642-5647
- URL: https://www.wjgnet.com/1007-9327/full/v13/i42/5642.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i42.5642